Europe’s biggest firm, whose sales of Wegovy almost doubled, feels it can ‘meet demands’ of US administration
Europe’s biggest company, Novo Nordisk, has rebuffed fears of a hit to its business from Donald Trump’s threatened tariffs as sales of its weight-loss drug Wegovy almost doubled.
Since the US president took office, he has imposed tariffs on Mexico and Canada – since paused for a month – and China, and has said levies of imports from the EU will “definitely happen”.
Continue reading...from World news | The Guardian https://ift.tt/fuwmX3W
No comments:
Post a Comment